Junwei Chen

250 East Changgang Rd
Guangzhou, 510260, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Long-term patency of the transjugular intrahepatic portosystemic shunt for portal and superior mesenteric vein thrombosis.

Long-term patency of the transjugular intrahepatic portosystemic shunt for portal and superior mesenteric vein thrombosis.

Journal: Thrombosis journal

Published: September 05, 2025

Identification and validation of an explainable machine learning model for hepatocellular carcinoma at high risk: a retrospective multicenter cohort study.

Identification and validation of an explainable machine learning model for hepatocellular carcinoma at high risk: a retrospective multicenter cohort study.

Journal: International journal of surgery (London, England)

Published: June 05, 2025

Extrasphincteric anal fistula with gluteal extension: A case report and literature review.

Extrasphincteric anal fistula with gluteal extension: A case report and literature review.

Journal: Medicine

Published: May 13, 2025

Prediction of bowel resection due to bowel necrosis in recent portal vein thrombosis based on CT presentations and clinical data.

Prediction of bowel resection due to bowel necrosis in recent portal vein thrombosis based on CT presentations and clinical data.

Journal: BMC gastroenterology

Published: April 18, 2025

Transcriptome Analysis Reveals the Molecular Mechanisms for Mycorrhiza-Enhanced Drought Tolerance in Maize by Regulating the Ca2+ Signaling Pathway.

Transcriptome Analysis Reveals the Molecular Mechanisms for Mycorrhiza-Enhanced Drought Tolerance in Maize by Regulating the Ca2+ Signaling Pathway.

Journal: Journal of fungi (Basel, Switzerland)

Published: March 21, 2025

Letter: Post-TIPS Hepatic Encephalopathy-The Long-Term Mortality Conundrum in Cirrhotic Patients With Portal Hypertension.

Letter: Post-TIPS Hepatic Encephalopathy-The Long-Term Mortality Conundrum in Cirrhotic Patients With Portal Hypertension.

Journal: Alimentary pharmacology & therapeutics

Published: March 01, 2025

TACE Combined with Lenvatinib-PD-1 Versus TACE Monotherapy as Conversion Therapy Before Liver Resection in Unresectable Hepatocellular Carcinoma: A Retrospective, Propensity Score Matching Study.

TACE Combined with Lenvatinib-PD-1 Versus TACE Monotherapy as Conversion Therapy Before Liver Resection in Unresectable Hepatocellular Carcinoma: A Retrospective, Propensity Score Matching Study.

Journal: Journal of hepatocellular carcinoma

Published: January 16, 2025

Transarterial Chemoembolization (TACE) Combined with Lenvatinib versus TACE Alone in Intermediate-Stage Hepatocellular Carcinoma Patients Beyond Up-To-Seven Criteria: A Retrospective, Propensity Score-Matched Analysis.

Transarterial Chemoembolization (TACE) Combined with Lenvatinib versus TACE Alone in Intermediate-Stage Hepatocellular Carcinoma Patients Beyond Up-To-Seven Criteria: A Retrospective, Propensity Score-Matched Analysis.

Journal: Academic radiology

Published: March 15, 2024

Hepatic artery infusion chemotherapy combined with camrelizumab plus rivoceranib for hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter propensity score-matching analysis.

Hepatic artery infusion chemotherapy combined with camrelizumab plus rivoceranib for hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter propensity score-matching analysis.

Journal: Hepatology international

Published: December 06, 2023

CXCL10 and Nrf2-upregulated mesenchymal stem cells reinvigorate T lymphocytes for combating glioblastoma.

CXCL10 and Nrf2-upregulated mesenchymal stem cells reinvigorate T lymphocytes for combating glioblastoma.

Journal: Journal for immunotherapy of cancer

Published: November 19, 2023

Efficiency and safety of hepatic arterial infusion chemotherapy (HAIC) combined with anti-PD1 therapy versus HAIC monotherapy for advanced hepatocellular carcinoma: A multicenter propensity score matching analysis.

Efficiency and safety of hepatic arterial infusion chemotherapy (HAIC) combined with anti-PD1 therapy versus HAIC monotherapy for advanced hepatocellular carcinoma: A multicenter propensity score matching analysis.

Journal: Cancer medicine

Published: August 03, 2023

Prognosis prediction and risk stratification of transarterial chemoembolization or intraarterial chemotherapy for unresectable hepatocellular carcinoma based on machine learning.

Prognosis prediction and risk stratification of transarterial chemoembolization or intraarterial chemotherapy for unresectable hepatocellular carcinoma based on machine learning.

Journal: European radiology

Published: April 19, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026